Tilray Brands

Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Toronto, Ontario. Tilray also has operations in Australia, New Zealand, Germany, Portugal, and Latin America.
Tilray Brands stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Tilray Brands balance sheet

Report period2020 2021 2022 2023 2024 Q1 25
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Tilray Brands cash flows

Report period2020 2021 2022 2023 2024 Q1 25 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Tilray Brands multipliers

Report period2020 2021 2022 2023 2024 Q1 25 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Tilray Brands profitability

Report period2020 2021 2022 2023 2024 Q1 25 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Tilray Brands assets
Tilray Brands cash flows

Tilray Brands dividend policy

The company does not pay dividends

Tilray Brands shares

TickerNameTypeNominal valueISINPrice
TLRY:USTilray BrandsCommon share-US88688T1007$1.93
Tilray Brands news
06.04.2022
Tilray's GAAP net income for 9 months of fiscal year 2022 was $23.668 million, compared to a loss of $369.636 million in the previous year. Revenue increased 28.1% to $475.047 million from $370.849 million a year earlier.
10.01.2022
Tilray's GAAP loss for 6 months of fiscal year 2022 was $28.807 million, down 3.9 times from $110.993 million in the prior year. Revenue increased 30.9% to $323.176 million from $246.949 million a year earlier.
08.12.2021
Tilray acquired Breckenridge Distillery, known for its collection of whiskey and bourbon under the Breckenridge brand. The terms of the deal were not disclosed.
07.10.2021
Tilray's GAAP loss for 3M 2022 fiscal year was $34.604 million, up 59.1% from $21.744 million in the prior year. Revenue increased 43% to $168.023 million from $117.49 million a year earlier.
General information
Company nameTilray Brands
Tags#pharmacy
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2 2064329325
Mailing address1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2
Websiteir.tilray.com
Information disclosurewww.sec.gov